MOG-antibody-associated disease—getting the whole picture

Abstract

Keywords

Demyelination MRI biomarkers

Get full access to this article

View all access options for this article.

References

Reindl

Waters

Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol 2019; 15(2): 89–102.

Bilodeau

Kumar

Rodriguez

, et al. MOG-IgG myelitis coexisting with systemic lupus erythematosus in the post-partum setting. Mult Scler 2020; 26: 997–1000.

Jarius

Ruprecht

Kleiter

, et al. MOG-IgG in NMO and related disorders: A multicenter study of 50 patients—Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation 2016; 13(1): 280.

Probstel

Thanei

Erni

, et al. Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosus. Rheumatology 2019; 58: 908–913.

Jiang

Shi

Gao

, et al. Clinical features of central nervous system infections and experience in differential diagnosis from neuropsychiatric lupus erythematosus in a cohort of 8491 patients with systemic lupus erythematosus. Arthritis Res Ther 2019; 21(1): 189.

Jarius

Paul

Aktas

, et al. MOG encephalomyelitis: International recommendations on diagnosis and antibody testing. J Neuroinflammation 2018; 15: 134.